Promius Pharma, LLC - Product Pipeline Review - 2016

  • ID: 3674294
  • Company Profile
  • 48 pages
  • Global Markets Direct
1 of 4
Promius Pharma, LLC - Product Pipeline Review - 2016

Summary

‘Promius Pharma, LLC - Product Pipeline Review - 2016’, provides an overview of the Promius Pharma, LLC’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Promius Pharma, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Promius Pharma, LLC
- The report provides overview of Promius Pharma, LLC including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Promius Pharma, LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Promius Pharma, LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Promius Pharma, LLC’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Promius Pharma, LLC
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Promius Pharma, LLC’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Promius Pharma, LLC Snapshot

Promius Pharma, LLC Overview

Key Information

Key Facts

Promius Pharma, LLC - Research and Development Overview

Key Therapeutic Areas

Promius Pharma, LLC - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Promius Pharma, LLC - Pipeline Products Glance

Promius Pharma, LLC - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Promius Pharma, LLC - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Promius Pharma, LLC - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Promius Pharma, LLC - Drug Profiles

DFD-01

Product Description

Mechanism of Action

R&D Progress

DFN-11

Product Description

Mechanism of Action

R&D Progress

tetracycline MR

Product Description

Mechanism of Action

R&D Progress

DFD-06

Product Description

Mechanism of Action

R&D Progress

DFD-10

Product Description

Mechanism of Action

R&D Progress

DFN-02

Product Description

Mechanism of Action

R&D Progress

ACT-01

Product Description

Mechanism of Action

R&D Progress

celecoxib

Product Description

Mechanism of Action

R&D Progress

DFN-10

Product Description

Mechanism of Action

R&D Progress

DFN-15

Product Description

Mechanism of Action

R&D Progress

DFN-14

Product Description

Mechanism of Action

R&D Progress

DFN-19

Product Description

Mechanism of Action

R&D Progress

DFD-04

Product Description

Mechanism of Action

R&D Progress

DFD-05

Product Description

Mechanism of Action

R&D Progress

DFD-08

Product Description

Mechanism of Action

R&D Progress

Small Molecules 1 for Epilepsy

Product Description

Mechanism of Action

R&D Progress

Small Molecules 1 for Parkinson's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecules 2 for Epilepsy

Product Description

Mechanism of Action

R&D Progress

Small Molecules 2 for Parkinson's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecules 3 for Epilepsy

Product Description

Mechanism of Action

R&D Progress

Small Molecules 3 for Parkinson's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecules 4 for Epilepsy

Product Description

Mechanism of Action

R&D Progress

Small Molecules 4 for Parkinson's Disease

Product Description

Mechanism of Action

R&D Progress

Promius Pharma, LLC - Pipeline Analysis

Promius Pharma, LLC - Pipeline Products by Target

Promius Pharma, LLC - Pipeline Products by Route of Administration

Promius Pharma, LLC - Pipeline Products by Molecule Type

Promius Pharma, LLC - Pipeline Products by Mechanism of Action

Promius Pharma, LLC - Recent Pipeline Updates

Promius Pharma, LLC - Dormant Projects

Promius Pharma, LLC - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Promius Pharma, LLC, Key Information

Promius Pharma, LLC, Key Facts

Promius Pharma, LLC - Pipeline by Indication, 2016

Promius Pharma, LLC - Pipeline by Stage of Development, 2016

Promius Pharma, LLC - Monotherapy Products in Pipeline, 2016

Promius Pharma, LLC - Pre-Registration, 2016

Promius Pharma, LLC - Phase III, 2016

Promius Pharma, LLC - Phase II, 2016

Promius Pharma, LLC - Phase I, 2016

Promius Pharma, LLC - Preclinical, 2016

Promius Pharma, LLC - Pipeline by Target, 2016

Promius Pharma, LLC - Pipeline by Route of Administration, 2016

Promius Pharma, LLC - Pipeline by Molecule Type, 2016

Promius Pharma, LLC - Pipeline Products by Mechanism of Action, 2016

Promius Pharma, LLC - Recent Pipeline Updates, 2016

Promius Pharma, LLC - Dormant Developmental Projects,2016

List of Figures

Promius Pharma, LLC - Pipeline by Indication, 2016

Promius Pharma, LLC - Pipeline by Stage of Development, 2016

Promius Pharma, LLC - Monotherapy Products in Pipeline, 2016

Promius Pharma, LLC - Pipeline by Target, 2016

Promius Pharma, LLC - Pipeline by Route of Administration, 2016

Promius Pharma, LLC - Pipeline by Molecule Type, 2016

Promius Pharma, LLC - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll